Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Predictmedix ( (TSE:PMED) ) has issued an update.
Predictmedix AI Inc. announced the successful closing of the final tranche of its non-brokered private placement, raising a total of $612,650. The company strategically selected participants who align with its long-term vision, focusing on maintaining share-structure integrity and avoiding unnecessary dilution. This disciplined approach aims to advance their initiatives across key markets with clarity and momentum.
Spark’s Take on TSE:PMED Stock
According to Spark, TipRanks’ AI Analyst, TSE:PMED is a Underperform.
The overall stock score for Predictmedix is driven by its significant financial challenges, including negative revenue and profitability, and a weak balance sheet. While technical indicators show short-term positive momentum, the company’s poor financial health and unattractive valuation metrics weigh heavily on its score.
To see Spark’s full report on TSE:PMED stock, click here.
More about Predictmedix
Predictmedix AI Inc. is an emerging provider in the health and safety technology industry, offering rapid health screening and remote patient care solutions globally. The company’s Smarthealth AI stations use multispectral cameras and proprietary artificial intelligence to analyze physiological data patterns, predicting health issues such as impairment, fatigue, and mental illnesses. Their remote patient care platform equips medical professionals with AI-powered tools to enhance patient health outcomes.
YTD Price Performance: 600%
Average Trading Volume: 274,302
Technical Sentiment Signal: Buy
Current Market Cap: C$13.62M
For detailed information about PMED stock, go to TipRanks’ Stock Analysis page.